NCT01639911 2019-07-22Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsUniversity of Illinois at ChicagoPhase 1 Completed28 enrolled
NCT01045421 2016-08-15Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal MalignanciesMillennium Pharmaceuticals, Inc.Phase 1/2 Completed273 enrolled 28 charts